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Abstract We tested the hypothesis that the use of supple-
mental oxygen (sO2) at discharge from the NICU in ex-
tremely preterm neonates is associated with a greater risk of
neurodevelopmental impairment (NDI) at 18 months
corrected gestational age (CGA) than the risk of NDI of
those neonates discharged in room air. Four hundred twenty-
four charts were retrospectively reviewed from infants born
at <27 weeks and transferred to Nationwide Children’s
Hospital from December 1, 2004 to June 14, 2010. Use of
sO2 was evaluated on day of life (dol) 28, at 36 weeks post-
menstrual age (PMA), and at discharge. Logistic regression
was used to identify postnatal risk factors associated with
sO2 at discharge and NDI. At dol 28, 96 % of surviving
patients received sO2, and therefore had bronchopulmonary
dysplasia (BPD) by definition from a National Institutes of
Child Health and Human Development workshop. At
36 weeks PMA, 89 % continued on sO2 (moderate/severe
BPD), and at discharge, 74 % continued on sO2. When
factors associated with NDI were examined, the need for
mechanical ventilation ≥28 days (adjOR=3.21, p=0.01),
grade III–IV intraventricular hemorrhage (IVH) (adjOR=
4.61, p<0.01), and discharge at >43 weeks PMA (adjOR=
2.12, p=0.04) were the strongest predictors of NDI at
18 months CGA. There was no difference in Bayley Scales
of Infant Development, third edition composite scores be-
tween patients with no/mild BPD and patients with
moderate/severe BPD (cognitive p=0.60, communication
p=0.53, motor p=0.19) or those scores between patients
on and off oxygen at discharge (cognitive p=0.58, commu-
nication p=0.70, motor p=0.62). Conclusions: The need for
sO2 at discharge is not associated with an increased risk of
NDI in these patients. The strongest predictors of poor
neurodevelopmental outcome in this population were
prolonged positive pressure support, grade III–IV IVH,
and discharge at >43 weeks PMA.
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Bronchopulmonary dysplasia (BPD) is the most common
chronic lung disease affecting preterm infants, and the inci-
dence of BPD is inversely related to gestational age [37]. In
1967, Northway first described BPD as a requirement for
supplemental oxygen (sO2) at day of life (dol) 28 with chest
X-ray findings demonstrating fibrosis and collapse
surrounded by areas of marked hyperinflation [26]. Over
the decades, a “new” BPD has emerged that is characterized
by fewer and larger alveoli, as well as decreased pulmonary
microvasculature development [11, 18, 20, 35]. The emer-
gence of “new” BPD and the improved survival of patients
born at extremely early gestational ages led to a new defi-
nition of BPD from a National Institutes of Child Health and
Human Development (NICHD) workshop [18]. Using this
definition and the inverse relationship to gestational age, the
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incidence of BPD in the extremely preterm infant is very
high. For example, Farstad et al. recently reported an inci-
dence of 86 % in a Norwegian cohort of patients born
between 22 and 27 completed weeks of gestation [12].
Given the high incidence of BPD in this population, we
examined the use of sO2 at discharge to determine incidence
and factors associated with sO2 use at discharge. Since BPD
has been associated with poor neurodevelopmental outcome
[3, 14, 17, 27–29, 31–34, 38], we tested the hypothesis that
the use of sO2 at discharge from the NICU in extremely
preterm neonates is associated with a greater risk of
neurodevelopmental impairment (NDI) at 18 months
corrected gestational age (CGA).
Methods
This study was approved by the Institutional Review Board
of the Nationwide Children’s Hospital (NCH). This is a
retrospective observational study. Charts were reviewed
and data obtained from all 424 patients who were born at
<27 weeks gestation and transferred to the NCH NICU
between December 1, 2004 and June 14, 2010. Only pa-
tients who survived, were not transferred, and had available
data at 28 days were included in the study (345 patients).
The NCH NICU is an all referral (i.e., no inborn patients)
level IV [1] center in Columbus, Ohio, USA, which receives
referrals from 22 hospitals in Central Ohio. The NICU
Small Baby Pod at NCH is a dedicated space and nursing
staff which allows for an interdisciplinary, standardized
approach to the care of the extremely preterm neonate born
at <27 completed weeks gestational age [24].
NICU data were abstracted from charts by trained per-
sonnel and entered into the Small Baby Database, which
contains basic demographic information and details of the
hospital course for each patient admitted to the Small Baby
Pod at NCH. Gestational age was determined by prenatal
ultrasound when available and confirmed by Ballard Score.
Since NCH is an all referral hospital, maternal data were
limited. For example, the presence of chorioamnionitis was
not reliably available on all patients. Oxygen status was
assessed at dol 28, 36 weeks post-menstrual age (PMA),
and at discharge. The attending physician prescribed the sO2
for these patients. At the time this study was conducted,
there was not a policy to include an oxygen challenge test at
36 weeks and supplemental oxygen was as prescribed by the
attending neonatologist. BPD was defined as a need for sO2
at dol 28 and then stratified based on the use of sO2 at
36 weeks PMA as per the definition from a NICHD work-
shop [18], where mild disease is defined as no sO2 at
36 weeks PMA, moderate BPD is defined as an sO2 require-
ment of <30 % at 36 weeks PMA, and severe BPD is
defined as an sO2 requirement of >30 % and/or positive
pressure support at 36 weeks PMA. Comorbidities were
assessed, including necrotizing enterocolitis (NEC) and in-
traventricular hemorrhage (IVH). Short-term outcome mea-
surements included sO2 at discharge and hospital length of
stay. Longer term outcomes included 18-month corrected
composite scores on the Bayley Scales of Infant Develop-
ment, third edition (BSID-III) assessment. Patients without
BPD were evaluated at routine follow-up visits in the neona-
tology outpatient clinic and patients with BPD were evaluated
at the Comprehensive Center for BPD at NCH [30]. NDI was
defined as any Bayley composite score (cognitive, communi-
cation, or motor) <80 or cerebral palsy [19, 22, 39].
Statistical analysis
Patients who were discharged to home (i.e., survived and
not transferred to another institution) were divided into two
groups. The first group consisted of those patients who did
not require sO2 at discharge. The second group consisted of
those patients who required sO2 at discharge. Continuous
variables, including BSID-III scores, were compared be-
tween groups using Student’s t test, and categorical vari-
ables, including NDI, were compared by χ2 analysis.
Logistic regression was used to model those factors poten-
tially associated with sO2 at discharge and NDI. Clinical
characteristics were chosen based on a priori interest and
included ≤24 weeks gestational age, birth weight ≤700 g,
Apgar score at 5 min ≤3, admission dol ≥7, CPAP ≥28 days,
mechanical ventilation ≥28 days, PDA ligation, surgical
NEC, grade III–IV IVH, discharge >43 weeks PMA, mod-
erate–severe BPD, and sO2 at discharge. Unadjusted and
adjusted odds ratios for NDI were also calculated for these
same clinical characteristics. All analyses were conducted
with STATA 12 statistical software (StataCorp. 2011. Stata
Statistical Software: Release 12. College Station, TX:
StataCorp LP). Boxplots were created using GraphPad
Prism version 6.00 for Windows (GraphPad Software, La
Jolla California USA, www.graphpad.com). A two-tailed p
value of <0.05 was considered statistically significant.
Results
Of the 424 patients admitted to NCH during the time of this
study, 16 (4 %) transferred prior to dol 28, 55 (13 %) died
prior to dol 28, and 8 (2 %) did not have available data at dol
28, such that there were 345 eligible patients at dol 28
(Fig. 1). Figure 1 also demonstrates the number of eligible
patients at 36 weeks PMA, discharge to home, and at 18-
month follow-up. It is of interest to note that for this highly
vulnerable patient group, the overall mortality rate during
the initial NICU stay was 20 % (86/424), and most of the
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mortality occurred before dol 28, resulting in a mortality rate
between dol 28 and discharge of 7 %. Furthermore, there
was no mortality in patients during their initial NICU
stay that were successfully weaned off of sO2 from dol
28 until discharge.
Table 1 summarizes sO2 use at dol 28, 36 weeks PMA,
and discharge in the extremely preterm infant stratified by
gestational age. For the entire group, 96 % of the patients
received sO2 at dol 28, 89 % continued to receive sO2 at
36 weeks PMA, and 74 % of the patients continued to
receive sO2 at discharge. Only 4 % of the patients did not
require sO2 at dol 28 and therefore, by NIH definition, did
not have BPD [18]. Even in this extremely preterm popula-
tion, the use of sO2 at any of the measured time points
tended to be greater as gestational age of the patient at birth
decreased (p<0.01).
Table 2 summarizes patient characteristics, selected
comorbidities, and NDI for this population. Those patients
who went home on sO2 were of lower gestational age
(p=0.02) and weighed at birth an average of 50 g less
than patients discharged on room air (p=0.03). Patients
discharged on sO2 had significantly (p<0.01) more days
on mechanical ventilation (58±51 days) than did pa-
tients discharged on room air (24±21 days). Patients
discharged on sO2 had a PDA ligation more often (52
vs. 36 %, p=0.02) and had less surgical NEC (8 vs.
28 %, p<0.01) than did patients discharged on room air.
NDI was similar between those discharged on room air
and those discharged on sO2 (51 vs. 47 %, p=0.67).
In the adjusted analysis of sO2 at discharge, patients
receiving CPAP for ≥28 days were more likely to go home
on oxygen (adjOR=2.9, 95 % CI 1.4–6.2, p<0.01). Simi-
larly, patients receiving ≥28 days of mechanical ventilation
were more likely to receive sO2 at discharge (adjOR=7.7,
95 % CI 2.9–20.5, p<0.01). We also found that there was a
significantly (p<0.01) greater proportion of patients in the
discharged home on room air group that were ventilated for
≤14 days (45 %) than in those discharged home on sO2
(20 %). Patients with surgical NEC were less likely to
receive sO2 at discharge (adjOR=0.11, 95 % CI 0.04–
0.30, p<0.01). None of the other factors in Table 2 were
significantly associated with sO2 at discharge in the logistic
regression model.
In order to further explore the relationship between
surgical NEC and sO2 at discharge, we analyzed the
characteristics of these 36 patients. The mortality rate
(after dol 28) for surgical NEC was 2/36 (6 %). Those
surgical NEC patients who were discharged on sO2
had a longer (p=0.02) duration of mechanical ventila-
tion (58±31 days) than did those surgical NEC pa-
tients discharged on room air (35±27 days). However,
patients with surgical NEC who went home on sO2
had a significantly shorter length of stay (surgical
NEC home on sO2 144±28 days vs. surgical NEC
home on room air 188±69 days, p=0.02) and their
PMA at time of discharge was less (46±4 weeks vs.
53±10 weeks, p<0.01) than those patients with surgi-
cal NEC who went home on room air.
Of the 276 patients who were discharged alive, 5 subse-
quently died and 231 (85 % of survivors) presented for an
18-month Bayley exam at their routine neonatal clinic
follow-up visit. Cerebral palsy was diagnosed in 30/231
(13 %) of those patients discharged alive who presented
for follow-up (Fig. 1). Given that Bayley scores were not
assigned for patients with cerebral palsy, Bayley scores were
available for 201 patients. Motor scores were not available
for three patients and communication scores were not avail-
able for two patients, due to inability to perform the test. For
the corrected cognitive scores, 54/201 (27 %) were <80; for
the corrected communication scores, 65/199 (33 %) were
<80; and for the corrected motor scores, 62/198 (31 %) were
<80. There were no significant differences in Bayley
scores between those patients with no/mild BPD and
moderate/severe BPD (Fig. 2a). Similarly, there were
Patients at 36 weeks PMA
n=297
264 (89%) on oxygen 
33 (11%) off oxygen
Patients at discharge
n=276
204 (74%) on oxygen
72 (26%) off oxygen
14/297 (5%) transferred
11/14 (79%) on oxygen, 
3/14 (21%) off oxygen
7/297 (2%) died
7/7 (100%) on oxygen
29/345 (8%) transferred 
26/29 (90%) on oxygen, 
3/29 (10%) off oxygen
19/345 (6%) died 
19/19 (100%) on oxygen
Patients at dol 28
n=345
331 (96%) on oxygen
14 (4%) off oxygen
Patients at 18 month neonatal clinic 
follow up
n=231
(30 patients, unable to assess Bayley 
score due to CP)
n=201
5/276 (2%) died
5/5 (100%) on oxygen
40/271 (15%) no follow-up 
Fig. 1 Patients admitted between December 1, 2004 and June 14,
2010. Three hundred forty-five patients born at <27 weeks gestation
were eligible for this study on day of life (dol) 28. At discharge, there
remained 276 patients of which 2 % died and 15 % did not return for
follow-up at the neonatal clinic. At 18 months corrected gestational
age, 30 patients had cerebral palsy (CP) and 201 patients had Bayley
scores available for analysis
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no significant differences in Bayley scores off and on
sO2 at discharge (Fig. 2b).
Table 3 summarizes the unadjusted and adjusted odds
ratios for NDI. Unadjusted odds ratios were significant for
predicting NDI for those patients born at ≤24 weeks gesta-
tional age, birth weight ≤700 g, mechanical ventilation
≥28 days, surgical NEC, grade III–IV IVH, and discharge
at >43 weeks PMA. After adjustment for all the factors in
Table 3, only ventilation for ≥28 days, grade III–IV IVH,
and discharge at >43 weeks PMA remained significantly
associated with NDI. Oxygen at discharge was not predic-
tive of NDI (adjOR 0.67, p=0.18).
Discussion
In this cohort of infants born at <27 weeks gestational age,
transferred to an all referral NICU, and surviving to dol 28,
the majority of surviving patients had BPD as defined by a
sO2 requirement on dol 28. Our data are consistent with a
recent study of a national cohort by The Norwegian Extreme
Prematurity Study Group, which found that 86 % of infants
born between 22 and 27 weeks gestation had BPD and that
80 % of infants born at 22 to 25 completed weeks gestation
had moderate-to-severe BPD [12]. In our retrospective co-
hort of infants referred to a level IV Children’s Hospital
NICU, 89 % had moderate-to-severe BPD. Unlike other
reported cohorts of extremely preterm infants, our rate of
moderate-to-severe BPD is likely influenced by the fact that
all of our patients are outborn. Outborn patients are referred
from several level III NICUs and include the sickest ex-
tremely preterm infants from throughout our region, many
of whom are referred when they remain on supplemental
oxygen. The NICHD Neonatal Research Network re-
cently reported that 43 % of inborn neonates <29 weeks
gestation had moderate-to-severe BPD [36]. Given that
the incidence of BPD is inversely related to gestational
age at birth [11, 12, 18, 20, 26, 35, 37], differences in
the gestational age of included infants likely contributes
to variation in published rates of moderate–severe BPD.
In our extremely preterm infants who survived to
discharge, the vast majority (74 %) were discharged
home on sO2. As expected, those patients requiring
sO2 at discharge were born earlier and weighed less
at birth than those patients who did not require sO2 at
discharge. Patients who went home on sO2 had a
longer duration of mechanical ventilation. We found
that the use of mechanical ventilation for ≥28 days is
the strongest predictor of need for sO2 at time of
discharge in these patients. In our patient cohort, there
was no difference in length of stay between patients
who were discharged on sO2 and those discharged on
room air. Therefore, it does not appear that patients
were being sent home on sO2 in order to hasten dis-
charge from the NICU.
We were surprised to find that patients with surgical NEC
were less likely to receive sO2 at discharge. Therefore, we
Table 1 Supplemental oxygen (sO2) use at day of life (dol) 28,
36 weeks post-menstrual age (PMA), and at discharge for patients









22–23 100 % (55/55) 91 % (42/46) 86 % (37/43)
24 98 % (95/97) 90 % (76/84) 75 % (56/75)
25 95 % (98/103) 91 % (82/90) 74 % (64/86)
26 92 % (83/90) 83 % (64/77) 65 % (47/72)
Total 96 % (331/345) 89 % (264/297) 74 % (204/276)
ªDenominator represents all infants alive and in the NICU at that point
in time. Percent (ratio) determined for dichotomous variables.
Table 2 Supplemental oxygen
(sO2) use at discharge according
to patient characteristics
ªAny Bayley composite score
(cognitive, communication, or
motor) <80 or cerebral palsy
Characteristics Total
(n=276)





Gestational age (weeks) 24.7±1.1 24.9±1.0 24.6±1.1 0.02
Birth weight (grams) 723±166 760±159 710±167 0.03
5-min Apgar score 6±2 6±2 6±2 0.17
Age on admission (dol) 11±12 11±12 10±12 0.44
CPAP (days) 35±19 31±16 36±20 0.06
Mechanical ventilation (days) 49±47 24±21 58±51 <0.01
PDA ligation 48 % (133/276) 36 % (26/72) 52 % (107/204) 0.02
Surgical NEC 13 % (36/276) 28 % (20/72) 8 % (16/204) <0.01
Grade III–IV IVH 21 % (59/275) 18 % (13/72) 23 % (46/203) 0.41
Length of stay (days) 146±61 136±54 150±63 0.08
Length of stay (PMA, weeks) 47±9 46±7 47±9 0.19
Neurodevelopmental Impairmentª 50 % (115/231) 47 % (26/55) 51 % (89/176) 0.67
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examined patient characteristics that might contribute to this
finding. Patients diagnosed with surgical NEC and
discharged home on room air had a significantly longer
length of stay, as well as greater PMA at discharge, than
those surgical NEC patients who were discharged on sO2.
This suggests that in the subgroup of patients with surgical
NEC, those discharged on room air remained in hospital
longer, and during this longer hospital stay (an average of
~7 weeks) were able to wean from sO2.
The BSID-III was used to assess neurodevelopmental
outcome. Recently, it has been suggested that the BSID-III
underestimates the severity of disability as compared to the
BSID-II [2, 19]. Therefore, we followed published recom-
mendations and used a composite score of <80 on any of the
three categories (cognitive, communication, or motor) or
cerebral palsy to denote NDI [22]. Our rates of NDI were
similar to a recent report by Moore et al. in the same
gestational age group [22]. There was no significant differ-
ence in Bayley scores between those patients with no/mild
BPD vs. moderate/severe BPD or those patients discharged
on sO2 vs. room air for any of the three categories. Thus,
BPD severity or need for sO2 at discharge in this cohort of
patients does not adversely affect neurodevelopmental out-
come. Although there is literature to suggest BPD predicts
worsening NDI, many of these patients were evaluated prior
to 2000 [3, 9, 25]. Other studies have suggested that BPD
may not be an independent r isk factor of poor
neurodevelopmental outcome [13]. Our study population
was evaluated between years 2004 and 2010, so it may be
that more recently there has been an improvement in
neurodevelopmental outcome in patients with BPD. Consis-
tent with this concept are at least three recent studies. Hintz
et al. found worsening rates of BPD while NDI remained
relatively constant over time [16]. The EPICure studies
found that in the most recent patient cohort compared to
earlier cohorts there were more neonates born at less than
27 weeks surviving without disability [21]. Finally, a recent
systematic review of NDI rates in extremely preterm infants
found a significant decrease in rates of cerebral palsy based
on increasing year of birth [6].
At NCH, we developed an innovative program directed at
this population of extremely preterm infants, the Small Baby
Program, that started on December 1, 2004 [23]. The adop-
tion of this program which is based on a standardized
approach to the care of these infants led to an improvement
in hospital outcomes [23]. Furthermore, we found improved
survival and neurodevelopmental outcomes at 18–24 months
compared to similar cohorts of patients [23]. We also found
at about the same time that the care given to patients with
established moderate-to-severe BPD was highly variable
and often lacked a neurodevelopmental focus during the
initial NICU stay. Therefore, we implemented a standard-
ized inpatient and outpatient program for these patients
focused on developmental needs [29]. These programs
may have impacted the favorable outcome that BPD patients
in this study had who were discharged home on supplemen-
tal oxygen.
There are some notable limitations of our study. The
population admitted to an all referral children’s hospital



















































































Fig. 2 BSID-III composite scores (cognitive, communication, and
motor) of neonates born at <27weeks gestation (n=201). Boxplots
represent median and interquartile range. a Boxplots comparing no/
mild BPD to those neonates with moderate/severe BPD. Student’s t test
for cognitive score (p=0.60), communication score (p=0.53), and
motor score (p=0.19). There was no significant difference (ns) be-
tween the no/mild BPD and moderate/severe BPD groups. b Boxplots
comparing no supplemental oxygen (sO2) at discharge to those
neonates receiving sO2 at discharge. Student's t test for cognitive
score (p=0.58), communication score (p=0.70), and motor score
(p=0.62). There was no significant difference (ns) between the no
sO2 at discharge and sO2 at discharge groups
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For example, in our referral area, most extremely preterm
infants are born in delivery hospitals with a level III NICU
and are only transferred if there is need for surgical or
subspecialty care. It should also be kept in mind that the
extremely preterm neonates included in our study have
survived both the delivery room and transport to our insti-
tution. We are an all referral center and therefore have
limited ability to extract maternal data, as well as resuscita-
tion data, from outside institutions for research purposes.
Also, our study included information on 18-month Bayley
scores; a recent systematic review found that higher rates of
attrition were associated with worse neurodevelopmental
outcome [15]. Although only 85 % of our patients returned
for follow-up, this is a relatively high follow-up rate for the
USA [6] and improved follow-up would be expected to
improve overall NDI. Lastly, at the time of this study, there
was no policy in place to objectively measure the need for
oxygen. However, since then, we have implemented a 36-
week oxygen challenge test and are following the data to
determine if there is a decrease in the incidence of BPD and
the use of supplemental oxygen at discharge.
The current definition of BPD depends on the need for
and the amount of sO2 given to a patient [4–8]. Oxygen
weaning varies by clinical practice among neonatologists
and among centers. This may be responsible for some of the
wide variation in BPD incidence among NICUs [10]. The
currently used criteria for defining BPD results in the vast
majority of patients born at <27 weeks having moderate-to-
severe BPD. This is consistent with recent studies from the
USA [6, 36], Norway [12], and Sweden [11] in a similar
gestational age cohort. Further studies are needed to de-
velop BPD phenotypes more specific to the extremely
preterm infant that could be used to more effectively
and efficiently develop preventative strategies and pre-
dict neonatal outcomes.
In summary, we report for the first time that the
need for sO2 at discharge is not an independent predic-
tor of poor neurodevelopmental outcome in patients
born before 27 completed weeks gestational age. When
examining variables that might predict discharge on
supplemental oxygen, not unexpectedly long-term me-
chanical ventilation was the most predictive of dis-
charge home on sO2 in this population. These findings
underscore the need to develop strategies and therapies
that decrease the length of time that mechanical venti-
lation is required to improve pulmonary outcomes in
these patients. Given that the diagnosis of BPD is based
on supplemental oxygen requirement, our data suggest
that in the extremely preterm infant BPD as currently
defined is found in nearly all patients. Therefore, we
suggest that for the neonate born at the edge of viability
there is a need for developing phenotypic criteria for
BPD in order to better characterize disease severity and
predict long-term outcomes. The data from this relatively
large and recent cohort of extremely preterm infants dem-
onstrate that discharge home on supplemental oxygen does
not in and of itself translate to a poor neurodevelopmental
outcome.
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Table 3 Unadjusted and adjusted
odds ratios for neurodevelop-
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patient characteristic
NDI defined as any Bayley
composite score (cognitive,
communication, or motor) <80
or CP
Unadjusted Adjusted
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